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Abstract
Sickle  cell  disease  is  hereditary  hemoglobinopathy which  causes  haemolytic anemia,  vaso
occlusive crisis, ischemic injuries and many other morbidities like cerebral infarction.  In this 
report, we describe a case of a young patient with sickle cel
sided weakness and slurring of speech with examination confirming right
with  motor  aphasia.  On  further  investigation,  she  was  found  to  have  frontotemporal 
infarction.  On magnetic resonance imaging with ang
circulation in left internal carotid artery probably secondary to sickle cell disease.  Major 
vessel occlusion is rare complication of sickle cell disease that one must bear in mind.
Introduction:  Sickle  cell  disease  is  the  most 
common  genetic  hemoglobinopathy  diseases 
characterized by hemolytic anemia and morbidities
like  painful  vaso-occlusive  crisis  and  ischemic 
injury.  It  also  predisposes  to  cerebral  infarcts  in 
relatively  younger  age.  Even  rarely  sickle  cell 
disease may result in vessel occlusion. In this case 
report we attempt to describe a rare case of major 
vessel  occlusion  in  a  young  patient  with  known 
sickle disease.
Case  Report:  A  22-year-old  Saudi  female 
presented to Emergency Department with a 2
history  of  right-sided  weakness  and  slurring  of 
speech  which  was  sudden  in  onset.    Her  past 
medical history was significant for ischemic stroke 
in the left frontal region 2 years back and for having 
sickle cell disease with  frequent  visits to hospital 
for  vaso-occlusive  crisis.    She  was  on  regular 
frequent  blood  transfusions  with  last  transfusion 
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Sickle  cell  disease  is  hereditary  hemoglobinopathy  which  causes  haemolytic  anemia,  vaso
occlusive crisis, ischemic injuries and many other morbidities like cerebral infarction.  In this 
report, we describe a case of a young patient with sickle cell disease presenting with right
sided weakness and slurring of speech with examination confirming right-sided hemiparesis 
with  motor  aphasia.  On  further  investigation,  she  was  found  to  have  frontotemporal 
infarction.  On magnetic resonance imaging with angiography, she was found to have absent 
circulation in left internal carotid artery probably secondary to sickle cell disease.  Major 
vessel occlusion is rare complication of sickle cell disease that one must bear in mind.
Sickle  cell  disease  is  the  most 
common  genetic  hemoglobinopathy  diseases 
by hemolytic anemia and morbidities
occlusive  crisis  and  ischemic 
poses  to  cerebral  infarcts  in 
relatively  younger  age.  Even  rarely  sickle  cell 
disease may result in vessel occlusion. In this case 
report we attempt to describe a rare case of major 
vessel  occlusion  in  a  young  patient  with  known 
old  Saudi  female 
presented to Emergency Department with a 2-day 
sided  weakness  and  slurring  of 
speech  which  was  sudden  in  onset.    Her  past 
medical history was significant for ischemic stroke 
ears back and for having 
sickle cell disease with frequent  visits to  hospital 
occlusive  crisis.    She  was  on  regular 
frequent  blood  transfusions  with  last  transfusion 
over three months ago.  Since her ischemic stroke, 
the patient had been on aspirin 81 mg daily.  She 
was vaccinated against Streptococcus pneumoniae,
Haemophilus  influenzae  type  B,  Neisseria 
meningitidis, with no indications of iron overload, 
taking  hydroxyurea  500  mg  daily  and  was  being 
regularly followed up in our sickle cell clinic.
had no history of smoking or illicit drug use. The 
patient was married with one kid but she was not 
taking any oral contraceptives.
Examination  revealed  right-sided  hemiparesis 
with motor aphasia. Her laboratory data is as shown 
in  the  table.  CT  scan  showed  frontotemporal 
ischemic  changes  suggestive  of  infarction. 
Suspicion for cortical venous thrombosis in light of 
sickle cell disease and predisposing thrombophilic 
tendency  lead  to  performing  an  MRI  Brain  with 
angiography that revealed near absent cir
left internal carotid artery.  
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Sickle  cell  disease  is  hereditary  hemoglobinopathy  which causes  haemolytic  anemia,  vaso-
occlusive crisis, ischemic injuries and many other morbidities like cerebral infarction.  In this 
l disease presenting with right-
sided hemiparesis 
with  motor  aphasia.  On  further  investigation,  she  was  found  to  have  frontotemporal 
iography, she was found to have absent 
circulation in left internal carotid artery probably secondary to sickle cell disease.  Major 
vessel occlusion is rare complication of sickle cell disease that one must bear in mind.
over three months ago.  Since her ischemic stroke, 
n 81 mg daily.  She 
was vaccinated against Streptococcus pneumoniae,
Haemophilus  influenzae  type  B,  Neisseria 
meningitidis, with no indications of iron overload, 
taking  hydroxyurea  500  mg  daily  and  was  being 
regularly followed up in our sickle cell clinic. She 
had no history of smoking or illicit drug use. The 
patient was married with one kid but she was not 
sided  hemiparesis 
with motor aphasia. Her laboratory data is as shown 
showed  frontotemporal 
ischemic  changes  suggestive  of  infarction. 
Suspicion for cortical venous thrombosis in light of 
sickle cell disease and predisposing thrombophilic 
tendency  lead  to  performing  an  MRI  Brain  with 
angiography that revealed near absent circulation in Medit J Hemat Infect Dis 2010; 2(1); Open Journal System 
Figure 1. (A to D) with figure 1A showing ischemic changes in left frontoparietal region on CT scan brain plain, with figure 1B 
showing similar findings on T2 FLAIR MRI brain with enhancement. Figure 1C showing absence of arterial supply in the left MCA
territory on MR angiogram while figure 1D showing absence of left internal carotid blood supply due to internal carotid occlusion.
Discussion: Occlusion of a major vessel like carotid 
artery is a rare complication of sickle cell disease 
which  has  been  reported  before.
1 Twenty-four 
percent of SCA patients suffer a stroke by the age 
of  45  which  carries  significant  morbidity  and 
mortality.
2 In  Saudi  sickle  cell  population  the 
presence  of  the  Mediterranean  G6PD  mutation 
(S188F) predisposes more to cerebral stroke.
3
Sickle cell  disease  is  an  inherited  disorder  of 
hemoglobin that is amongthe most common genetic 
diseases in the world. It is characterized by lifelong 
hemolytic  anemia  and  many  other  significant 
morbidities largely  related  to  painful  and 
debilitating  vaso-occlusive  phenomenon.
4  Sickle 
cell disease (SCD) was first described in 1910, in a 
dental  student  who  presented  with  pulmonary 
symptoms.
5 Herrick coined the term “sickle-shaped” 
to describe the peculiar appearance of the red blood 
cell of this patient.  However,  given the patient’s 
symptoms, he was not sure at the time whether theMedit J Hemat Infect Dis 2010; 2(1); Open Journal System 
Table 1: Laboratory Data of the Patient
Hemoglobin 7.8 gm/dl Urea 4.2 mmol/L
White blood cells 16.4 Creatinine 67 mmol/L
Platelets 451 Alanine aminotranferase 41 IU/L
Hemoglobin S 76% Bilirubin 44 mmol/L
blood  condition  was  a  disease  sui  generis  or  a 
manifestation  of  another  disease.
6  Ingram  and 
colleagues demonstrated shortly thereafter that the 
mutant  sickle  hemoglobin  (Hb  S)  differed  from 
normal hemoglobin A by a single amino acid.
7 This 
was followed by studies that analyzed the structure 
and  physical  properties  of  Hb  S,  which  formed 
intracellular  polymers  upon  deoxygenation.
8  The 
clinical manifestations of sickle cell anemia (SCA) 
result  primarily  from  hemolytic  anemia  and  the 
effects  of  repeated  intravascular  sickling,  causing 
vasoocclusion  and  ischemic  injury  while  lower 
levels of fetal hemoglobin (Hb F) and higher white 
blood  cell  (WBC)  counts  are  associated  with  an 
increased  incidence  of  SCA-related  events,  organ 
damage, and mortality.
9
The  chronic  organ  damage  in  SCA  is  an 
insidious  process  that  may  affect  almost  every 
organ  system  and  can  lead  to  considerable 
morbidity and mortality at an early  age  including 
loss  of  splenic  function,
10  sickle  nephropathy 
(proteinuria  and  renal  insufficiency),
11  pulmonary 
hypertension,
12  and  brain  ischemic  lesions,
13  are 
examples of long-term end-organ damage observed 
in SCA.  The Stroke Prevention Trial in Sickle Cell 
Anemia (STOP)  trial has demonstrated that the risk 
of stroke due to SCD is 10% per year in children 
not  undergoing  transfusion  and  1%  per  year  in 
children undergoing regular blood transfusion.
14,15
Conclusion: The idea behind this manuscript is to 
highlight that major vessel occlusion causing stroke 
in patients with sickle cell disease is a possibility 
which  should  be  kept  in  mind  by  emergency 
physicians.
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